CN104324231A - 具有止痛健胃功能的海蒲胃宁胶囊配方生产工艺及其应用 - Google Patents
具有止痛健胃功能的海蒲胃宁胶囊配方生产工艺及其应用 Download PDFInfo
- Publication number
- CN104324231A CN104324231A CN201410397003.3A CN201410397003A CN104324231A CN 104324231 A CN104324231 A CN 104324231A CN 201410397003 A CN201410397003 A CN 201410397003A CN 104324231 A CN104324231 A CN 104324231A
- Authority
- CN
- China
- Prior art keywords
- stomach
- pain
- production technology
- capsule
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000002193 Pain Diseases 0.000 title claims abstract description 29
- 239000002775 capsule Substances 0.000 title claims abstract description 16
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 15
- 241000245665 Taraxacum Species 0.000 title abstract 4
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 title abstract 4
- 210000002784 stomach Anatomy 0.000 claims abstract description 45
- 230000036407 pain Effects 0.000 claims abstract description 26
- 206010000087 Abdominal pain upper Diseases 0.000 claims abstract description 18
- 208000007882 Gastritis Diseases 0.000 claims abstract description 15
- 238000002360 preparation method Methods 0.000 claims abstract description 15
- 208000023652 chronic gastritis Diseases 0.000 claims abstract description 7
- 206010061218 Inflammation Diseases 0.000 claims abstract description 5
- 206010029333 Neurosis Diseases 0.000 claims abstract description 4
- 230000001154 acute effect Effects 0.000 claims abstract description 4
- 208000015238 neurotic disease Diseases 0.000 claims abstract description 4
- 230000002048 spasmolytic effect Effects 0.000 claims abstract description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 16
- 239000003814 drug Substances 0.000 claims description 13
- 229940069428 antacid Drugs 0.000 claims description 8
- 239000003159 antacid agent Substances 0.000 claims description 8
- 230000001458 anti-acid effect Effects 0.000 claims description 8
- 238000005728 strengthening Methods 0.000 claims description 8
- 241000218176 Corydalis Species 0.000 claims description 7
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 7
- 230000000844 anti-bacterial effect Effects 0.000 claims description 6
- 239000007963 capsule composition Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000005242 forging Methods 0.000 claims description 4
- 208000010470 Ageusia Diseases 0.000 claims description 3
- 230000036592 analgesia Effects 0.000 claims description 3
- 239000000812 cholinergic antagonist Substances 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 208000024891 symptom Diseases 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 19
- 230000002496 gastric effect Effects 0.000 abstract description 8
- 241000894006 Bacteria Species 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 7
- 210000004369 blood Anatomy 0.000 abstract description 7
- 208000025865 Ulcer Diseases 0.000 abstract description 5
- 231100000397 ulcer Toxicity 0.000 abstract description 5
- 206010020601 Hyperchlorhydria Diseases 0.000 abstract description 2
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 210000001198 duodenum Anatomy 0.000 abstract 2
- 239000002131 composite material Substances 0.000 abstract 1
- 238000001647 drug administration Methods 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 description 8
- 208000008469 Peptic Ulcer Diseases 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 210000004211 gastric acid Anatomy 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 239000008194 pharmaceutical composition Substances 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 206010000269 abscess Diseases 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010067171 Regurgitation Diseases 0.000 description 3
- 241000130764 Tinea Species 0.000 description 3
- 208000002474 Tinea Diseases 0.000 description 3
- 241000223238 Trichophyton Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 208000011906 peptic ulcer disease Diseases 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 241000589902 Leptospira Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 241000700584 Simplexvirus Species 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000605008 Spirillum Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 229940036811 bone meal Drugs 0.000 description 2
- 239000002374 bone meal Substances 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 108010006161 conchiolin Proteins 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000000718 duodenal ulcer Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 229940037467 helicobacter pylori Drugs 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- TVZRAEYQIKYCPH-UHFFFAOYSA-N 3-(trimethylsilyl)propane-1-sulfonic acid Chemical compound C[Si](C)(C)CCCS(O)(=O)=O TVZRAEYQIKYCPH-UHFFFAOYSA-N 0.000 description 1
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102000011195 Profilin Human genes 0.000 description 1
- 108050001408 Profilin Proteins 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241001441745 Sepia esculenta Species 0.000 description 1
- 241001663378 Sepiella maindroni Species 0.000 description 1
- 241000238371 Sepiidae Species 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 206010061577 Ulcer haemorrhage Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 230000003602 anti-herpes Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000941 anti-staphylcoccal effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 1
- 238000002575 gastroscopy Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 235000006109 methionine Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000004264 monolayer culture Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000009854 mucosal lesion Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 229960000381 omeprazole Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 208000023482 precordial pain Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/758—Zanthoxylum, e.g. pricklyash
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明涉及一种具有止痛健胃功能的海蒲胃宁胶囊配方、生产工艺及其临床应用,研究发现,由海螵蛸与蒲公英等十三种中药组成的海蒲胃宁胶囊,具有明显的制酸、止痛、抗菌、止血、消炎作用,该制剂经当地药监部门批准,作为医院制剂凭医生处方在临床应用,历时20年,已证明该制剂对胃、十二指肠溃疡、急慢性胃炎、胃神经官能症引起的胃痛、胃脘灼热、隐隐作痛有明显的疗效,对各种胃疼痛均有十分显著的止痛及解痉作用,有效率达95%以上,用胃镜检查观察本品对胃、十二指肠溃疡、复合性溃疡等,证实本品有极好的疗效,有效率达86%,未发现不良反应。
Description
技术领域 一种具有止痛健胃功能的海蒲胃宁胶囊配方、生产工艺及其临床应用,属于中药的生产技术领域及临床医疗领域。
背景技术 胃痛是一种临床很常见的疾病症状,中医也称为胃脘痛,指由于脾胃受损,气血不调所引起胃脘部疼痛的病证,历代文献中所称的“心痛”、“心下痛”,多指胃痛而言。如《素问.六元正纪大论》说:“民病胃脘当心而痛。”《医学正传》说:“古方九种心痛……。详其所由,皆在胃脘,而实不在于心。”至于心脏疾息所引起的心痛症,《黄帝内经》曾指出:“真心痛,手足青至节,心痛甚,旦发夕死,夕发旦死”,在临床上与胃痛是有区别的。胃痛发生的常见原因有寒邪客胃、饮食伤胃、肝气犯胃和脾胃弱等。中医认为,胃主受纳腐熟水谷,若寒邪客于胃中,寒凝不散,阻滞气机,可致胃气不和而疼痛或因饮食不节,饥饱无度,或过食肥甘,食滞不化,气机受阻,胃失和降引起胃痛;肝对脾胃有疏泄作用,如因恼怒抑郁,气郁伤肝,肝失条达,横逆犯胃,亦可发生胃痛;若劳倦内伤,久病脾胃虚弱,或禀赋不足,中阳亏虚,胃失温养,内寒滋生,中焦虚寒而痛;亦有气郁日久,瘀血内结,气滞血瘀,阻碍中焦气机,而致胃痛发作总之,胃痛发生的病机分为虚实两端,实证为气机阻滞,不通则痛;虚证为胃腑失于温煦或濡养,失养则痛。
海螵蛸为乌贼科动物无针乌贼或金乌贼的内壳,是常用的中药,味咸、涩,性微温。归肝、肾经。功效收敛止血、固精止带、制酸敛疮。其化学成分主要含有碳酸钙80~85%,壳角质6~7%,粘液质10~15%,并含少量磷酸钙、氯化钠及镁、钾、锌、铜、铝等10多种无机元素。此外,内壳中含蛋氨酸、天冬氨酸、谷氨酸等17种氨基酸。中医的功用主治为除湿,制酸,止血,敛疮。治胃痛吞酸,吐、衄、呕血,便血,崩漏带下,血枯经闭,腹痛症瘕,虚疟泻痢,阴蚀烂疮。收敛止血,涩精止带,用于胃痛吞酸,吐血衄血,崩漏便血,遗精滑精,赤白带下;溃疡病。外治损伤出血,疮多脓汁。现代药理研究认为海螵蛸主要有(1)中和胃酸(2)保护胃黏膜及抗溃疡作用。中和胃酸是由于海螵蛸主要含碳酸钙,尚含壳角质、黏液质、磷酸钙等,碳酸钙中和盐酸是制止胃酸过多的主要作用机理。有人用酸碱中和法测定海螵蛸制酸量,结果测得1g海螵蛸能中和浓度为0.1mol/L的盐酸溶液140~150ml,其中碳酸钙是中和胃酸的有效成分。但也有人证明海螵蛸提取的多糖组分也有显著升高pH,中和胃酸的作用。用海螵蛸中提取的多糖组分预处理小鼠3d和5d,再用无水乙醇诱导其胃黏膜损伤,结果证实多糖组分CBP-s对乙醇诱导的小鼠胃黏膜具有细胞保护作用,其机制除提高胃酸的pH外,还可能与提高组织中的一氧化氮(NO)、谷胱甘肽(GSH)的含量相关。还有学者采用DSS诱导法建立小鼠UC模型,注射不同浓度海螵蛸多糖CPS-1,连续7d,研究其对UC的保护作用,结果表明海螵蛸多糖CPS-1能够明显提高UC小鼠血液中表皮细胞生长因子(EGF)和血小板衍生生长因子(PDGF)的含量,加速溃疡组织的愈合,同时可降低肿瘤坏死因子的表达,从而缓解炎症。
海螵蛸在临床上主要用于治疗胃、十二指肠溃疡,海螵蛸配合其他药物内服,对溃疡病及其引起的出血、穿孔,均有较好疗效。如有报道用海螵蛸骨粉85%,浙贝母粉15%,混合,每次服2~5克,每日3次饭前服,或于上述散剂中再加入大黄10%,可纠正海螵蛸易引起便秘的副作用。亦有报道用海螵蛸30克炒黄,配伍半夏3克研末混合,用于溃疡病有制酸、止血、止痛等作用。一般服药后3~5日即开始生效,食欲转佳,吞酸及上腹部疼痛减轻或消失,大便恢复为黄色。多数患者经1~3个月治疗后症状、体征均消失或显著改善,X线复查壁龛消失或有进步。海螵蛸骨粉与白及粉等量混合,每日3~4次,每次3~5克,温开水调服,可用于溃疡病出血,据数十例观察,一般在3~7日内,即收到止血效果:呕血停止,便色恢复正常,大便潜血试验阴转。在中医治疗消化性溃疡的药方上,海螵蛸作为一味重要成分被广泛使用,在治疗胃食管反流病和治疗慢性胃炎也同样使用到了海螵蛸。
蒲公英为菊科蒲公英属多年生草本植物。蒲公英植物体中含有蒲公英醇、蒲公英素、胆碱、有机酸、菊糖等多种健康营养成分。蒲公英性味甘,微苦,寒。归肝、胃经。有利尿、缓泻、退黄疸、利胆等功效。治热毒、痈肿、疮疡、内痈、目赤肿痛、湿热、黄疸、小便淋沥涩痛、疔疮肿毒,乳痈,瘰疬,牙痛,目赤,咽痛,肺痈,肠痈,湿热黄疸,热淋涩痛。治急性乳腺炎,淋巴腺炎,瘰疬,疔毒疮肿,急性结膜炎,感冒发热,急性扁桃体炎,急性支气管炎,胃炎,肝炎,胆囊炎,尿路感染等。现代药理研究,蒲公英具有广谱的抑菌作用,对革兰氏阳性菌、革兰氏阴性菌、真菌、螺旋体等多种病原微生物均有不同程度的抑制作用,研究表明,蒲公英对金色葡萄球菌、表皮葡萄球菌、溶血性链球菌、卡他球菌均有显著的抑制作用,蒲公英和磺胺增效剂甲氧苄氨嘧啶(TMP)之间有增强抗菌作用,最佳比例为蒲公英2.5g∶TMP10mg;蒲公英煎剂有抗金黄色葡萄球菌作用,其最小抑菌浓度(MIC)为0.5g/ml,其抗菌作用机制是一方面通过抑制细胞壁合成,另一方面是通过抑制蛋白质和DNA的合成来实现的。蒲公英对大肠杆菌、绿脓杆菌、葡萄球菌、费弗氏痢疾杆菌、副伤寒杆菌甲、白色念珠菌等均有一定抑制作用。蒲公英浸出液滤纸片对金黄色葡萄球菌、变形杆菌、甲型链球菌、乙型链球菌均有明显抑菌作用,蒲公英在体外抑菌作用明显,蒲公英提取物试管法试验,对人型结核杆菌(H37RV)有抑菌作用,蒲公英水浸剂(1∶4)在试管内对堇色毛癣菌、同心性毛癣菌、许兰氏毛癣菌、奥杜盎氏小芽胞癣菌、铁锈色小芽胞癣菌、羊毛状小芽胞癣菌、石膏样小芽胞癣菌、腹股沟表皮癣菌、星形奴卡氏菌等均有抑制作用,试管内试验,蒲公英对黄疸出血型10多种菌型钩端螺旋体均有抑制作用,对不同菌型强度并无明显差别,且水煎剂强于醇浸剂。蒲公英乙醇提取物31mg/ml浓度能杀死钩端螺旋体,15mg/ml浓度则是有暂时性抑制作用。蒲公英煎剂及95%乙醇提取液均以10mg/ml浓度经管外、同时、治疗、预防四种途径给药,对I型单纯疱疹病毒(HSV-I)原代有胚肌皮单层细胞培养方法试验,表明有抗单纯疱疹病毒的作用。总之,蒲公英具有广谱抑菌作用,对革兰氏阳性菌、革兰氏阴性菌、真菌、螺旋体和病毒均有不同程度的抑制作用(参见吴艳玲,等,蒲公英的药理研究进展,2004)。还有学者证明蒲公英与阿莫西林、甲硝唑抗幽门螺杆菌疗效相似,但具有药源广、价格低、不良反应少的优点(李东明,奥美拉唑联合蒲公英治疗幽门螺杆菌阳性的慢性浅表性胃炎58例I临床疗效观察,中国医疗前沿,2009)。蒲公英还有胃肠保护作用,对各型胃脘痛患者,蒲公英能够清热润胃,消炎止痛,药性轻灵,清热而不伤胃,养阴而不恋邪,且无壅滞之弊。有报道蒲公英治疗慢性浅表性胃炎、慢性胃炎疗效显著,对胃脘痛的治疗疗效十分满意。现代药理研究证明,蒲公英还有利胆保肝作用,抗炎作用,抗氧化作用,提高免疫功能作用,抗胃损伤作用,利尿作用及抗肿瘤作用等。
发明内容 本研究组发现由海螵蛸与蒲公英组成的复方制剂,有较好的制酸、抗菌、止血、止痛作用,对临床常见的急性胃炎,慢性胃炎及消化性溃疡病有较好的疗效,进一步研究证明,在海螵蛸与蒲公英组成的复方制剂的基础上,添加延胡索、浙贝母、救必应、香附、白及、白术、白芍、九里香、瓦楞子(煅)、两面针、甘草,共十三味中药组成新的复方制剂海蒲胃宁胶囊,该制剂止痛健胃作用更好,该制剂经本省药监部门批准,作为医院制剂凭医生处方在临床应用,已证明该制剂有制酸、解痉、镇痛、收敛、抗菌消炎作用,可作为止痛健胃药物用于胃、十二指肠溃疡、急慢性胃炎、胃神经官能症引起的胃痛、胃脘灼热、隐隐作痛的用途,临床观察证明,本制剂对各种胃疼痛均有十分显著的止痛及解痉作用,有效率达95%以上,用胃镜检查观察本品对胃、十二指肠溃疡、复合性溃疡等,证实本品有极好的疗效,有效率达86%,未发现不良反应。
本发明提出的以海螵蛸与蒲公英为主药组成的海蒲胃宁胶囊的药物配方及剂量如下:海螵蛸210g,蒲公英325g,延胡索160g,浙贝母245g,救必应260g,香附160g,白及160g,白术160g,白芍160g,九里香160g,瓦楞子(煅)160g,两面针160g,甘草160g。该药物配方及剂量做成胶囊剂,可以做成1000粒。
本发明提出的以上海螵蛸与蒲公英为主药组成的海蒲胃宁胶囊的生产工艺先取海螵蛸适量,粉碎成超微细粉,余者与蒲公英、延胡索、浙贝母、救必应、香附、白及、白术、白芍、九里香、瓦楞子、两面针、甘草一起,加水煮提二次,每次1.5小时,过滤,合并滤液,浓缩成清膏,加入海螵蛸超微细粉,80℃烤干,粉碎,装入胶囊,即得。
本发明提出的海蒲胃宁胶囊的生产工艺,先取海螵蛸适量,粉碎成超微细粉,是指先取海螵蛸20~30克,粉碎成超微细粉,在其他药物浓缩成清膏后,再加入海螵蛸超微细粉,海螵蛸的最佳剂量是22克。
本发明提出的海蒲胃宁胶囊的药物配方及组成用量,还可添加药剂学方面的辅料,制成软胶囊,片剂,颗粒剂,冲剂,口服液供临床应用。
具体实施方式:
实施例一 根据本发明提出的海蒲胃宁胶囊的药物配方及生产工艺,取中药材海螵蛸210g,蒲公英325g,延胡索160g,浙贝母245g,救必应260g,香附160g,白及160g,白术160g,白芍160g,九里香160g,瓦楞子(煅)160g,两面针160g,甘草160g,按常规进行药材鉴定后,先取海螵蛸适量,粉碎成超微细粉,余者与蒲公英、延胡索、浙贝母、救必应、香附、白及、白术、白芍、九里香、瓦楞子、两面针、甘草一起,加水煮提二次,每次1.5小时,过滤,合并滤液,浓缩成清膏,加入海螵蛸超微细粉,80℃烤干,粉碎,装入胶囊,共制得胶囊1000粒。
按以上药物配方及生产工艺制得的海蒲胃宁胶囊,作为医院制剂,在本单位凭医生处方使用,历时20年,证明本制剂具有制酸、解痉、镇痛、收敛、抗菌消炎等作用;对胃、十二指肠溃疡、急慢性胃炎、胃神经官能症引起的胃痛、胃脘灼热、隐隐作痛有明显的止痛作用,没有出现不良反应。
Claims (6)
1.具有止痛健胃功能的海蒲胃宁胶囊配方生产工艺及其应用。
2.如权利要求1所述的具有止痛健胃功能的海蒲胃宁胶囊配方及其生产工艺,其特征是指该胶囊的配方为每1000粒含有下述中药的提取物:海螵蛸210g,蒲公英325g,延胡索160g,浙贝母245g,救必应260g,香附160g,白及160g,白术160g,白芍160g,九里香160g,瓦楞子(煅)160g,两面针160g,甘草160g。
3.如权利要求1所述的具有止痛健胃功能的海蒲胃宁胶囊配方及其生产工艺,其特征是指该胶囊的生产工艺是先取海螵蛸适量,粉碎成超微细粉,余者与蒲公英、延胡索、浙贝母、救必应、香附、白及、白术、白芍、九里香、瓦楞子、两面针、甘草一起,加水煮提二次,每次1.5小时,过滤,合并滤液,浓缩成清膏,加入海螵蛸超微细粉,80℃烤干,粉碎,装入胶囊,即得。
4.如权利要求3所述的具有止痛健胃功能的海蒲胃宁胶囊的生产工艺,其特征是海螵蛸粉碎成超微细粉的药量为20~30克。
5.如权利要求1所述的具有止痛健胃功能的海蒲胃宁胶囊配方及其生产工艺,其特征是该配方还可添加药剂学方面的辅料,制成软胶囊,片剂,颗粒剂,冲剂,口服液供临床应用。
6.如权利要求1~5所述的具有止痛健胃功能的海蒲胃宁胶囊,其特征是该制剂具有制酸、解痉、镇痛、收敛、抗菌消炎作用,可作为止痛健胃药物用于胃、十二指肠溃疡、急慢性胃炎、胃神经官能症引起的胃痛、胃脘灼热、隐隐作痛的临床症状。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410397003.3A CN104324231A (zh) | 2014-08-07 | 2014-08-07 | 具有止痛健胃功能的海蒲胃宁胶囊配方生产工艺及其应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410397003.3A CN104324231A (zh) | 2014-08-07 | 2014-08-07 | 具有止痛健胃功能的海蒲胃宁胶囊配方生产工艺及其应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104324231A true CN104324231A (zh) | 2015-02-04 |
Family
ID=52399121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410397003.3A Pending CN104324231A (zh) | 2014-08-07 | 2014-08-07 | 具有止痛健胃功能的海蒲胃宁胶囊配方生产工艺及其应用 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104324231A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116211979A (zh) * | 2023-04-25 | 2023-06-06 | 周富淦 | 一种中药保胃散及其制备方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101085219A (zh) * | 2007-06-14 | 2007-12-12 | 郑艳红 | 治疗胃溃疡的中药方剂 |
| CN103919895A (zh) * | 2014-04-21 | 2014-07-16 | 郑家林 | 一种调理肠胃、治疗便秘的中药酒 |
-
2014
- 2014-08-07 CN CN201410397003.3A patent/CN104324231A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101085219A (zh) * | 2007-06-14 | 2007-12-12 | 郑艳红 | 治疗胃溃疡的中药方剂 |
| CN103919895A (zh) * | 2014-04-21 | 2014-07-16 | 郑家林 | 一种调理肠胃、治疗便秘的中药酒 |
Non-Patent Citations (4)
| Title |
|---|
| 刁金囡: "中西结合治疗消化性溃疡86例疗效观察", 《河北中医》 * |
| 南京药学院《中草药学》编写组: "《中草药学》", 31 March 1980 * |
| 邹节明: "《广西特色中草药资源选编》", 31 August 2011 * |
| 黄少芳: "加味乌及散合云南白药治疗消化性溃疡42例临床观察", 《甘肃中医学院学报》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116211979A (zh) * | 2023-04-25 | 2023-06-06 | 周富淦 | 一种中药保胃散及其制备方法 |
| CN116211979B (zh) * | 2023-04-25 | 2024-05-24 | 周富淦 | 一种中药保胃散及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2089213C1 (ru) | Средство для фитокоррекции | |
| CN103385993B (zh) | 一种治疗胃溃疡的中药制剂及制备方法 | |
| CN103721103B (zh) | 用于治疗猪丹毒的药物及其制备方法 | |
| CN103536826B (zh) | 一种治疗阴道炎的中药组合物及其制备方法 | |
| CN110974887A (zh) | 一种抗肺癌的中药组合物 | |
| CN112535709A (zh) | 一种治疗结肠炎的中药组成物 | |
| CN108042727A (zh) | 一种治疗咽炎的药物组合物 | |
| CN106615512A (zh) | 一种茄子蜂蜜润喉糖及其制备方法 | |
| CN104800760A (zh) | 一种治疗肝胃郁热型反流性食管炎的中药组合物 | |
| CN104324231A (zh) | 具有止痛健胃功能的海蒲胃宁胶囊配方生产工艺及其应用 | |
| CN105213794B (zh) | 一种治疗口腔溃疡的中药组合物及其制备方法 | |
| CN110063977B (zh) | 一种党参、沙棘复合冲剂及其应用 | |
| CN102670922B (zh) | 治疗痢疾青葙子中药口服液及制备方法 | |
| CN105213991A (zh) | 用于治疗胃食管反流病的中药组合物 | |
| CN105056078A (zh) | 一种治疗胃火炽盛牙痛口臭的中药组合物 | |
| CN104127533B (zh) | 复方支气管炎糖浆及制备方法 | |
| CN103520550A (zh) | 一种治疗外寒内饮型慢性支气管炎的中药及制备方法 | |
| CN105168847A (zh) | 一种用于治疗幽门螺杆菌感染性消化性溃疡的中药 | |
| CN104998189A (zh) | 一种治疗风热乘脾型小儿口疮的中药散剂及其制备方法 | |
| CN106110285B (zh) | 一种用于治疗上呼吸道及食管道疾病的中药组合物及其制剂和应用 | |
| CN104971210A (zh) | 治疗脚癣的外洗剂及其制备方法 | |
| CN104906352A (zh) | 一种治疗虚火上炎型小儿口疮的中药药液及其制备方法 | |
| CN103520444A (zh) | 一种治疗湿热痰郁型慢性支气管炎的中药及制备方法 | |
| CN106309926A (zh) | 蜂产品及药食两用食物治疗胃炎胃溃疡的组合物 | |
| CN104398977A (zh) | 一种用于治疗功能性消化不良的中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150204 |